The role of vitamin D in prostate cancer
- 9 February 2001
- Vol. 66 (3-5) , 293-300
- https://doi.org/10.1016/s0039-128x(00)00164-1
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- 1 ,25-Dihydroxyvitamin D3 Inhibits Prostate Cancer Cell Growth by Androgen-Dependent and Androgen-Independent MechanismsEndocrinology, 2000
- Editorial/Mini-Review: Vitamin D and Prostate CancerEndocrinology, 2000
- Induction of Androgen Receptor by 1 ,25-Dihydroxyvitamin D3 and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer CellsEndocrinology, 1999
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- 1,25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Act Synergistically to Inhibit the Growth of LNCaP Prostate Cells and Cause Accumulation of Cells in G1Endocrinology, 1997
- Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25- dihydroxyvitamin D3Molecular Endocrinology, 1995
- Studies on the human prostatic cancer cell line LNCaPThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genesJournal of Surgical Oncology, 1991
- Vitamin D: A modulator of cell proliferation and differentiationThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981